Benjamin F. Edwards & Company, Inc. Bio Rad Laboratories, Inc. Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.51 Billion
- Q1 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 56 shares of BIO stock, worth $15,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56
Previous 38
47.37%
Holding current value
$15,396
Previous $12,000
58.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BIO
# of Institutions
489Shares Held
17.8MCall Options Held
44.9KPut Options Held
79.7K-
Vanguard Group Inc Valley Forge, PA2.42MShares$666 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.48MShares$407 Million0.01% of portfolio
-
Veritas Asset Management LLP1.15MShares$315 Million3.33% of portfolio
-
State Street Corp Boston, MA874KShares$240 Million0.01% of portfolio
-
Earnest Partners LLC Atlanta, GA515KShares$142 Million0.84% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.77B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...